Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00529841 · ClinicalTrials.gov registry record · NA
Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia
A NA study of Adrenal Hyperplasia, Congenital, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT00529841 is a NA study of Adrenal Hyperplasia, Congenital that has completed, run by Baylor College of Medicine. The registered enrollment target is 7 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00529841, a NA study of Adrenal Hyperplasia, Congenital, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a more physiological approach to the management of children and adolescents with salt wasting Congenital Adrenal Hyperplasia. We will administer the glucocorticosteroid via insulin infusion pump to see whether this treatment will improve the serum hormone concentrations.
Conditions Studied
Interventions
- DRUG Hydrocortisone sodium acetate
Study Locations (1)
Texas
- BCM, Texas Children's Hospital Clinic and General Clinical Research Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00529841
The ClinicalTrials.gov registry entry for NCT00529841 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adrenal Hyperplasia, Congenital appearing as the primary indexed condition, and to 1 intervention - of which Hydrocortisone sodium acetate is the first listed.
NCT00529841 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00529841 about?
NCT00529841 is a clinical study titled "Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia". The purpose of this study is to develop a more physiological approach to the management of children and adolescents with salt wasting Congenital Adrenal Hyperplasia. We will administer the glucocorticosteroid via insulin infusion pump to see whether this treatment will improve the serum hormone con...
What is the current status of trial NCT00529841?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2007-01. Estimated completion is 2008-09.
What conditions does trial NCT00529841 study?
This clinical trial studies the following conditions: Adrenal Hyperplasia, Congenital.
What interventions are being tested in trial NCT00529841?
The interventions under investigation include: Hydrocortisone sodium acetate (DRUG).
Who is sponsoring clinical trial NCT00529841?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00529841 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adrenal Hyperplasia, Congenital
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.